Citation Impact
Citing Papers
Multivariate Analysis of Prognostic Factors Among 2,313 Patients With Stage III Melanoma: Comparison of Nodal Micrometastases Versus Macrometastases
2010
The Prognostic Value of Circulating Tumor Cells in Patients with Melanoma: A Systematic Review and Meta-analysis
2006
Systemic Therapy for Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: ASCO Guideline Update
2022
Breast cancer
2019 Standout
Clinical implications of molecular heterogeneity in triple negative breast cancer
2015
Cancer statistics, 2017
2017 Standout
Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?
2009
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Blood Neutrophil-to-Lymphocyte Ratio is Prognostic in Gastrointestinal Stromal Tumor
2012
Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis
2009
Melanoma Patients with an Unknown Primary Tumor Site Have a Better Outcome than Those with a Known Primary Following Therapeutic Lymph Node Dissection for Macroscopic (Clinically Palpable) Nodal Disease
2014
Gastrointestinal Stromal Tumors
2012
Gastrointestinal Stromal Tumors II: Medical Oncology and Tumor Response Assessment
2009
Emerging strategies for TNBC with early clinical data: new chemoimmunotherapy strategies
2022
Phase I clinical trial of combination imatinib and ipilimumab in patients with advanced malignancies
2017 StandoutNobel
Comparison of Sentinel Lymph Node Micrometastatic Tumor Burden Measurements in Melanoma
2013
Modeling the efficacy of trastuzumab-DM1, an antibody drug conjugate, in mice
2010
Nomograms in oncology: more than meets the eye
2015 Standout
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
2011 Standout
Blood neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios are independent prognostic factors for surgically resected gastrointestinal stromal tumors
2015
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Dendritic Cell Cancer Therapy: Vaccinating the Right Patient at the Right Time
2018
ETV1 is a lineage survival factor that cooperates with KIT in gastrointestinal stromal tumours
2010 Nature
The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients
2013
Isolation of rare circulating tumour cells in cancer patients by microchip technology
2007 StandoutNature
Gastrointestinal stromal tumors - definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis
2001 Standout
Sentinel Lymph Node Biopsy in Thin Cutaneous Melanoma: A Systematic Review and Meta-Analysis
2016
Phase II trial of neoadjuvant/adjuvant imatinib mesylate (IM) for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumor (GIST): Early results of RTOG 0132/ACRIN 6665
2008
Influence of Sentinel Lymph Node Tumor Burden on Survival in Melanoma
2010
Cancer testis antigen expression in gastrointestinal stromal tumors: New markers for early recurrence
2008
Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs)
2008
Value of micromorphometric criteria of sentinel lymph node metastases in predicting further nonsentinel lymph node metastases in patients with melanoma
2011
Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual
2017 Standout
Diagnosis and multi-disciplinary management of hepatic metastases from gastrointestinal stromal tumour (GIST)
2009
Mitotic rate correlates with sentinel lymph node status and outcome in cutaneous melanoma greater than 1 millimeter in thickness: A multi-institutional study of 1524 cases
2016
Pathologic examination of sentinel lymph nodes from melanoma patients
2008
Data Set for Pathology Reporting of Cutaneous Invasive Melanoma
2013
Malignant melanoma of unknown primary site. To make the long story short. A systematic review of the literature
2010
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
2011 StandoutNobel
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
2010 Standout
Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate
2009
Thyroid Dysfunction as an Unintended Side Effect of Anticancer Drugs
2013
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Sex Is an Independent Prognostic Indicator for Survival and Relapse/Progression-Free Survival in Metastasized Stage III to IV Melanoma: A Pooled Analysis of Five European Organisation for Research and Treatment of Cancer Randomized Controlled Trials
2013
Colocalization of Inflammatory Response with B7-H1 Expression in Human Melanocytic Lesions Supports an Adaptive Resistance Mechanism of Immune Escape
2012 Standout
Breast Cancer Statistics, 2022
2022 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Works of Zbigniew Nowecki being referenced
Functional features of gene expression profiles differentiating gastrointestinal stromal tumours according to KITmutations and expression
2009
Adjuvant vaccination with melanoma antigen-pulsed dendritic cells in stage III melanoma patients
2012
Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate
2006
The Survival Benefit to Patients with Positive Sentinel Node Melanoma After Completion Lymph Node Dissection May Be Limited to the Subgroup with a Primary Lesion Breslow Thickness Greater Than 1.0 and Less Than or Equal to 4 mm (pT2–pT3)
2008
Diagnostic yield and safety of endoscopic-ultrasound guided trucut biopsy in patients with gastric submucosal tumors: a prospective study
2009
Detection of circulating melanoma cells in peripheral blood by a two-marker RT-PCR assay
2001
The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study
2012
Sentinel Node Tumor Burden According to the Rotterdam Criteria Is the Most Important Prognostic Factor for Survival in Melanoma Patients
2008
Predictive factors for long-term effects of imatinib therapy in patients with inoperable/metastatic CD117(+) gastrointestinal stromal tumors (GISTs)
2007
Survival Analysis and Clinicopathological Factors Associated With False-Negative Sentinel Lymph Node Biopsy Findings in Patients with Cutaneous Melanoma
2006
Melanoma without a Detectable Primary Site with Metastases to Lymph Nodes
2010
Risk Criteria and Prognostic Factors for Predicting Recurrences After Resection of Primary Gastrointestinal Stromal Tumor
2007
Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institution's experience
2003
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 study
2020
Prognosis in Patients With Sentinel Node–Positive Melanoma Is Accurately Defined by the Combined Rotterdam Tumor Load and Dewar Topography Criteria
2011
Prognostic Value of Multiple Reverse Transcription-PCR Tyrosinase Testing for Circulating Neoplastic Cells in Malignant Melanoma
2003
KEYNOTE-355: Randomized, double-blind, phase III study of pembrolizumab + chemotherapy versus placebo + chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer.
2020
The outcome of special histologic types of triple-negative breast cancer (TNBC).
2014